Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Top Cited Papers
- 1 September 2016
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 68 (10), 1116-1139
- https://doi.org/10.1016/j.jacc.2016.03.512
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary StentingThe New England Journal of Medicine, 2012
- Grabbing the Horns of a DilemmaCirculation, 2012
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingCirculation, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsJournal of the American College of Cardiology, 2011
- Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting StentsThe New England Journal of Medicine, 2010
- Drug-Eluting Stent Thrombosis in Routine Clinical PracticeCirculation: Cardiovascular Interventions, 2009
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2007
- Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA TrialJournal of the American College of Cardiology, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsCirculation, 2007
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents: An Observational Study of Drug-Eluting Versus Bare-Metal StentsJournal of the American College of Cardiology, 2006